Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control

Generated Narrative: Group 172480

version: 7; Last updated: 2023-12-04 16:22:54+0000

Profile: OutcomeDefinition

Artifact related artifact: No display for RelatedArtifact (type: cite-as; citation: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 172480. Revised 2023-11-02. Available at: https://fevir.net/resources/Group/172480. Computable resource at: https://fevir.net/resources/Group/172480.)

Artifact Title: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control

Artifact URL: https://fevir.net/resources/Group/172480

Artifact Publisher: Computable Publishing LLC

Artifact Copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

Artifact Contact: support@computablepublishing.com

Artifact Author: Brian S. Alper:

org/fhir/uv/ebm/StructureDefinition/combination-method: all-of

Artifact Status: active

identifier: FEvIR Object Identifier/172480

name: OutcomeDefinition_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control

description:

The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years

type: Animal

membership: Definitional

characteristic

org/fhir/uv/ebm/StructureDefinition/characteristic-description:

hemoglobin A1c less than 7.0%

CharacteristicTiming

  • contextCode: Enrollment in clinical trial
  • offset: No display for Duration (value: 5; unit: years; system: http://unitsofmeasure.org; code: a)
  • text: at 5 years

code: Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol

value: <7 % (Details: UCUM code% = '%')

exclude: false

characteristic

org/fhir/uv/ebm/StructureDefinition/characteristic-description:

low-density lipoprotein cholesterol less than 100 mg/dL

CharacteristicTiming

  • contextCode: Enrollment in clinical trial
  • offset: No display for Duration (value: 5; unit: years; system: http://unitsofmeasure.org; code: a)
  • text: at 5 years

code: Cholesterol in LDL [Mass/volume] in Serum or Plasma

value: <100 mg/dL (Details: UCUM codemg/dL = 'mg/dL')

exclude: false

characteristic

org/fhir/uv/ebm/StructureDefinition/characteristic-description:

systolic blood pressure less than 130 mm Hg

CharacteristicTiming

  • contextCode: Enrollment in clinical trial
  • offset: No display for Duration (value: 5; unit: years; system: http://unitsofmeasure.org; code: a)
  • text: at 5 years

code: Systolic blood pressure

value: <130 mm Hg (Details: UCUM codemm[Hg] = 'mm[Hg]')

exclude: false